Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited

SUNPHARMA

Rangering i aksjer #525
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Aksjekurs
$19.24
Sist synkronisert: 2026-10-19
Markedsverdi
$46.15B
Endring (1 dag)
-0.97%
Endring (1 år)
0.11%
Land
IN
Handel Sun Pharmaceutical Industries Limited (SUNPHARMA)

Kategori

Healthcare
Utbyttehistorikk for Sun Pharmaceutical Industries Limited (SUNPHARMA)
Sun Pharmaceutical Industries Limited (aksjesymbol: SUNPHARMA) har gitt totalt 38 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $100.09
Utbytteavkastning (TTM): 0.0091
Utbyttebetalinger for Sun Pharmaceutical Industries Limited (SUNPHARMA) fra 1996 til 2026
Årlige utbyttebetalinger
År Utbytte (justert for aksjesplitt) Endre
2026 (TTM) $11.00 -31.25%
2025 $16.00 18.52%
2024 $13.50 17.39%
2023 $11.50 15.00%
2022 $10.00 33.33%
2021 $7.50 87.50%
2020 $4.00 45.45%
2019 $2.75 37.50%
2018 $2.00 -42.86%
2017 $3.50 250.00%
2016 $1.00 -66.67%
2015 $3.00 100.00%
2014 $1.50 -40.00%
2013 $2.50 17.65%
2012 $2.13 21.43%
2011 $1.75 27.27%
2010 $1.38 0.00%
2009 $1.38 30.95%
2008 $1.05 55.56%
2007 $0.675 22.73%
2006 $0.55 46.67%
2005 $0.375 15.38%
2004 $0.325 30.00%
2003 $0.25 100.00%
2002 $0.125 0.00%
2001 $0.125 275.38%
2000 $0.0333 -70.29%
1999 $0.1121 146.92%
1998 $0.0454 55.48%
1997 $0.0292 40.38%
1996 $0.0208 0.00%
Liste over alle utbyttebetalinger
År Utbytte Endre
2026 (TTM) $11.00 -31.25%
2025 $16.00 18.52%
2024 $13.50 17.39%
2023 $11.50 15.00%
2022 $10.00 33.33%
2021 $7.50 87.50%
2020 $4.00 45.45%
2019 $2.75 37.50%
2018 $2.00 -42.86%
2017 $3.50 250.00%
2016 $1.00 -66.67%
2015 $3.00 100.00%
2014 $1.50 -40.00%
2013 $2.50 -41.18%
2012 $4.25 21.43%
2011 $3.50 -74.55%
2010 $13.75 0.00%
2009 $13.75 30.95%
2008 $10.50 55.56%
2007 $6.75 22.73%
2006 $5.50 46.67%
2005 $3.75 15.38%
2004 $3.25 -35.00%
2003 $5.00 0.00%
2002 $5.00 0.00%
2001 $5.00 25.00%
2000 $4.00 -71.43%
1999 $14.00 133.33%
1998 $6.00 71.43%
1997 $3.50 40.00%
1996 $2.50 0.00%
Utbyttebetalinger for lignende selskaper eller konkurrenter